Michael Amoroso
Chief Executive Officer bei PRECISION BIOSCIENCES, INC.
Vermögen: 873 863 $ am 31.03.2024
Aktive Positionen von Michael Amoroso
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ABEONA THERAPEUTICS INC. | Chairman | 14.10.2021 | - |
Director/Board Member | 19.03.2021 | 14.10.2021 | |
Chief Executive Officer | 19.03.2021 | 14.10.2021 | |
Chief Operating Officer | 01.11.2020 | 19.03.2021 | |
Corporate Officer/Principal | 09.07.2020 | 01.11.2020 | |
President | 19.03.2021 | 14.10.2021 | |
PRECISION BIOSCIENCES, INC. | Director/Board Member | 15.10.2021 | - |
Chief Executive Officer | 15.10.2021 | - | |
President | 15.10.2021 | - |
Karriereverlauf von Michael Amoroso
Ehemalige bekannte Positionen von Michael Amoroso
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KITE PHARMA INC | Corporate Officer/Principal | 01.08.2018 | 01.01.2020 |
Ausbildung von Michael Amoroso
Rider University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
PRECISION BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Börse
- Insiders
- Michael Amoroso
- Erfahrung